Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression

被引:148
作者
Clarke, TR
Hoshiya, Y
Yi, SE
Liu, XH
Lyons, KM
Donahoe, PK
机构
[1] Massachusetts Gen Hosp, Pediat Surg Res Labs, Dept Surg, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA
关键词
D O I
10.1210/me.15.6.946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Signal reception of Mullerian inhibiting substance (MIS) in the mesenchyme around the embryonic Mullerian duct in the male is essential for regression of the duct. Deficiency of MIS or of the MIS type II receptor, MISRII, results in abnormal reproductive development in the male due to the maintenance of the duct. MIS is a member of the transforming growth factor-beta (TGF beta) superfamily of secreted protein hormones that signal through receptor complexes of type I and type II serine/threonine kinase receptors. To investigate candidate MIS type I receptors, we examined reporter construct activation by MIS. The bone morphogenetic protein (BMP)-responsive Tlx2 and Xvent2 promoter-driven reporter constructs were stimulated by MIS but the TGF beta /activin-induced p3TP-lux or CAGA-luc reporter constructs were not. The induction of Tlx2-luc was dependent upon the kinase activity of MISRII and was blocked by a dominant negative truncated ALK2 (tALK2) receptor but not by truncated forms of the other BMP type I receptors ALK1, ALK3, or ALK6. MIS induced activation of a Gal4DBD-Smad1 but not a Gal4DBD-Smad2 fusion protein. This activation could also be blocked by tALK2. The BMP-induced inhibitory Smad, Smad6, was up-regulated by MIS endogenously in Leydig cell-derived lines and is expressed in male but not female Mullerian duct mesenchyme. ALK6 has been shown to function as an MIS type I receptor. Investigation of the pattern of ALK2, MISRII, and ALK6 in the developing urogenital system demonstrated overlapping expression of ALK2 and MISRII in the mesenchyme surrounding the duct while ALK6 was observed only in the epithelium. Examination of ALK6-/- male animals revealed no defect in duct regression. The reporter construct analysis, pattern of expression of the receptors, and analysis of ALK6-deficient animals suggest that ALK2 is the MIS type I receptor involved in Mullerian duct regression.
引用
收藏
页码:946 / 959
页数:14
相关论文
共 72 条
[1]   Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members [J].
Afrakhte, M ;
Morén, A ;
Jossan, S ;
Itoh, S ;
Westermark, B ;
Heldin, CH ;
Heldin, NE ;
ten Dijke, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) :505-511
[2]  
Allard S, 2000, DEVELOPMENT, V127, P3349
[3]  
ANDERSSON S, 1989, J BIOL CHEM, V264, P8222
[4]  
BAARENDS WM, 1994, DEVELOPMENT, V120, P189
[5]   THE IN-VIVO ROLES OF MULLERIAN-INHIBITING SUBSTANCE [J].
BEHRINGER, RR .
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 29, 1994, 29 :171-187
[6]   MULLERIAN-INHIBITING SUBSTANCE FUNCTION DURING MAMMALIAN SEXUAL DEVELOPMENT [J].
BEHRINGER, RR ;
FINEGOLD, MJ ;
CATE, RL .
CELL, 1994, 79 (03) :415-425
[7]   Sertoli cell signaling by Desert hedgehog regulates the male germline [J].
Bitgood, MJ ;
Shen, LY ;
McMahon, AP .
CURRENT BIOLOGY, 1996, 6 (03) :298-304
[8]  
Candia AF, 1997, DEVELOPMENT, V124, P4467
[9]   ISOLATION OF THE BOVINE AND HUMAN GENES FOR MULLERIAN INHIBITING SUBSTANCE AND EXPRESSION OF THE HUMAN-GENE IN ANIMAL-CELLS [J].
CATE, RL ;
MATTALIANO, RJ ;
HESSION, C ;
TIZARD, R ;
FARBER, NM ;
CHEUNG, A ;
NINFA, EG ;
FREY, AZ ;
GASH, DJ ;
CHOW, EP ;
FISHER, RA ;
BERTONIS, JM ;
TORRES, G ;
WALLNER, BP ;
RAMACHANDRAN, KL ;
RAGIN, RC ;
MANGANARO, TF ;
MACLAUGHLIN, DT ;
DONAHOE, PK .
CELL, 1986, 45 (05) :685-698
[10]   Mullerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung [J].
Catlin, EA ;
Tonnu, VC ;
Ebb, RG ;
Pacheco, BA ;
Manganaro, TF ;
Ezzell, RM ;
Donahoe, PK ;
Teixeira, J .
ENDOCRINOLOGY, 1997, 138 (02) :790-796